Press Releases

PR: Nemechek Tech Seeks FDA Emergency Use Authorization, July 20, 2020

OVERLAND PARK, KS, July 20, 2020  — Nemechek Technologies has applied to the FDA for an Emergency Use Authorization (EUA) for its Vitality Smartcable device. Originally sold as a wellness device, the Vitality Smartcable is currently being used in a COVID-19 clinical trial to assess the therapeutic effect of transcutaneous auricular vagus nerve stimulation (taVNS). The …

PR: Nemechek Tech Seeks FDA Emergency Use Authorization, July 20, 2020 Read More »

PR: Clinical Trial Begins Enrollment, July 9, 2020

Vagus Nerve Stimulation (VNS) Clinical Trial Begins Enrolling COVID-19 Patients OVERLAND PARK, Kan., July 9, 2020 /PRNewswire/ — COVID-19 patients have begun enrolling in an interventional clinical trial at Hospital Virgen del Carmen in Zarate, Argentina. The study will evaluate the therapeutic effect of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with pneumonia associated with the disease. Hospital Virgen del …

PR: Clinical Trial Begins Enrollment, July 9, 2020 Read More »

PR: Bioelectric Medicine and Coronavirus? ,June 29, 2020

Is Bio-Electric Medicine the Next Frontier of Therapy for Coronavirus Victims? Just Published – Dr. Patrick Nemechek proposes new technology to suppress COVID-19 cytokine storm. Overland Park, Kansas, June 29, 2020 – Nemechek Technologies, LLC announced the publication of a peer-reviewed article by Patrick Nemechek D.O. in The Journal of Integrative Clinical Medicine.  Entitled, ‘Transcutaneous …

PR: Bioelectric Medicine and Coronavirus? ,June 29, 2020 Read More »

PR: VNS for COVID-19?, June 22, 2020

‘Vagus Nerve Stimulation is an Ideal Therapeutic Candidate for COVID-19 Infection’ Patrick Nemechek, D.O. – Published in The Journal of Emerging Diseases and Virology OVERLAND PARK, KANSAS, UNITED STATES, June 22, 2020 /EINPresswire.com/ — Nemechek Technologies, LLC announced the publication of a peer-reviewed article by Patrick Nemechek D.O. on the advantages of vagus nerve stimulation …

PR: VNS for COVID-19?, June 22, 2020 Read More »

PR: NemeTech Enters Collaborative Agreement, June 2, 2020

Proposed South African Study Targets COVID-19 with Bio-Electric Therapy Vagus Nerve Stimulation (VNS) trial seeks to mitigate the deadly Cytokine Storm. Overland Park, Kansas, June 2, 2020 –Nemechek Technologies, Overland Park, Kansas and LT Clinical Research (Pty) LTD, Centurion, South Africa have agreed to collaborate to establish a clinical trial focused on the therapeutic effect …

PR: NemeTech Enters Collaborative Agreement, June 2, 2020 Read More »

PR: Planning Clinical Trial of VNS vs. COVID-19, May 20, 2020

Bio-Electric Therapy Targets Deadly COVID-19 Cytokine Storm Vagus Nerve Stimulation (VNS) Trial Seeks to Mitigate Dangerous Immune Response. Overland Park, Kansas, May 20, 2020 – Dr. Patrick Nemechek, founder of Nemechek Technologies, registered a study with ClinicalTrials.Gov to determine the therapeutic effect of transcutaneous vagus nerve stimulation (tVNS) in patients with moderate, severe, or critical …

PR: Planning Clinical Trial of VNS vs. COVID-19, May 20, 2020 Read More »

Receive the latest news

Subscribe for News and Updates